Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer

FRIDAY, Sept. 4, 2026-- For patients with prostate cancer, adverse pathological features are prognostic, but do not modify the benefit of adding hormone therapy (HT) to postoperative radiotherapy, according to a study published online July 28 in...